Airsculpt Technologies Inc
NASDAQ:AIRS
P/OCF
Price to OCF
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
Market Cap | P/OCF | ||||
---|---|---|---|---|---|
US |
Airsculpt Technologies Inc
NASDAQ:AIRS
|
248m USD | 11.8 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
89B EUR | 8.3 | |
US |
Cigna Corp
NYSE:CI
|
94.5B USD | 8.1 | ||
US |
CVS Health Corp
NYSE:CVS
|
71.9B USD | 6.6 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17.4B USD | 14.8 | ||
DE |
Fresenius SE & Co KGaA
XETRA:FRE
|
15.6B EUR | 3.7 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
16B USD | 12 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.8B EUR | 4.5 | |
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.8B EUR | 4.5 | ||
US |
DaVita Inc
NYSE:DVA
|
12.4B USD | 8.5 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -30.6 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.